ARVN · Arvinas Inc
United States · RS rating 12 · As of 2026-10-14
| Price | 6.82 USD |
|---|---|
| 1-day change | -0.3% |
| RS rating (overall / 1M / 3M / 12M) | 12 / 13 / 24 / 21 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 16 / 16 / 10 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -129.2% |
| Sales growth Q/Q | -77.3% |
| Distance from 52-week high | +50.7% |
| Market cap (USD) | $666.5M |